Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2244-2250
Published online before print September 22, 2005, doi: 10.1161/01.STR.0000182237.20807.d0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/10/2244    most recent
01.STR.0000182237.20807.d0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ten, V. S.
Right arrow Articles by Pinsky, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ten, V. S.
Right arrow Articles by Pinsky, D. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Neuroprotectors

(Stroke. 2005;36:2244.)
© 2005 American Heart Association, Inc.


Original Contributions

C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal Mice

Vadim S. Ten, MD, PhD; Sergei A. Sosunov, PhD; Sean P. Mazer, MD; Raymond I. Stark, MD; Casper Caspersen, PhD; Michael E. Sughrue, MD; Marina Botto, PhD; E. Sander Connolly, Jr, MD David J. Pinsky, MD

From the Departments of Pediatrics (V.S.T., R.I.S., C.C.), Medicine (S.P.M.), and Neurosurgery (S.A.S., M.E.S.,E.S.C.), Columbia University College of Physicians and Surgeons, New York, NY; Rheumatology Section (M.B.), Faculty of Medicine, Imperial College, London, UK; and Department of Medicine (D.J.P.), University of Michigan, Ann Arbor, MI.

Correspondence to Vadim S. Ten, MD, PhD, 3959 Broadway CHN 1201, New York, NY 10032. E-mail vt82{at}columbia.edu

Background and Purpose— This study was undertaken to determine whether the initial component of the classical complement (C) activation pathway contributes to hypoxic-ischemic brain injury in neonatal mice.

Methods— Hypoxia-ischemia (HI) was produced in C1q–/– and wild-type (WT) neonatal mice. At 24 hours after HI, neonatal mouse reflex performance and cerebral infarct volume were assessed. Long-term outcomes were measured by water-maze performance and degree of cerebral atrophy at 7 to 8 weeks after HI. Activation of circulating neutrophils, and C1q, C3, and neutrophil deposition in brains were examined.

Results— C1q–/– mice were significantly protected against HI (mean±SE infarct volume in C1q–/– mice=17.3±5.5% versus 53.6±6.8% in WT mice; P<0.0001) and exhibited significantly less neurofunctional deficit compared with WT mice. Immunostaining revealed significantly greater deposition of C3 (and C1q) as well as granulocytes in the infarcted brains in WT mice compared with C1q–/– animals. Activation of circulating leukocytes was significantly decreased in C1q–/– mice compared with WT mice, which correlated strongly (r=0.7) with cerebral infarct volumes.

Conclusions— Cerebral deposition of C1q and C3 after hypoxic-ischemic insult is associated with significantly greater neurologic damage in WT mice compared with C1q–/– mice, providing strong evidence that the classical C pathway contributes to the hypoxic-ischemic brain injury. Significantly decreased activation of circulating neutrophils associated with diminished local accumulation and attenuation of brain injury in C1q–/– mice suggests a potential cellular mechanism by which C1q mediates neurodegeneration in HI.


Key Words: hypoxia • inflammation • ischemia • mice • neuroprotection




This article has been cited by other articles:


Home page
J Child NeurolHome page
H. Hagberg, C. Mallard, C. I. Rousset, and Xiaoyang Wang
Apoptotic Mechanisms in the Immature Brain: Involvement of Mitochondria
J Child Neurol, September 1, 2009; 24(9): 1141 - 1146.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
M. D. Galvan, S. Luchetti, A. M. Burgos, H. X. Nguyen, M. J. Hooshmand, F. P. T. Hamers, and A. J. Anderson
Deficiency in Complement C1q Improves Histological and Functional Locomotor Outcome after Spinal Cord Injury
J. Neurosci., December 17, 2008; 28(51): 13876 - 13888.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Taniguchi, I. Mohri, H. Okabe-Arahori, K. Aritake, K. Wada, T. Kanekiyo, S. Narumiya, M. Nakayama, K. Ozono, Y. Urade, et al.
Prostaglandin D2 Protects Neonatal Mouse Brain from Hypoxic Ischemic Injury
J. Neurosci., April 18, 2007; 27(16): 4303 - 4312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Atkinson, H. Zhu, F. Qiao, J. C. Varela, J. Yu, H. Song, M. S. Kindy, and S. Tomlinson
Complement-Dependent P-Selectin Expression and Injury following Ischemic Stroke
J. Immunol., November 15, 2006; 177(10): 7266 - 7274.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J Mocco, W. J. Mack, A. F. Ducruet, S. A. Sosunov, M. E. Sughrue, B. G. Hassid, M. N. Nair, I. Laufer, R. J. Komotar, M. Claire, et al.
Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia
Circ. Res., July 21, 2006; 99(2): 209 - 217.
[Abstract] [Full Text] [PDF]